Non-invasive Brain Stimulation Using Tdcs of the Third (of Many) Visual Pathways — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Non-invasive Brain Stimulation Using Tdcs of the Third (of Many) Visual Pathways — Stella

Recruiting

Back to SCHIZOPHRENIA 1 (Disorder) trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Nathan Kline Institute, Orangeburg, New York

Key details

Sponsor

Nathan Kline Institute for Psychiatric Research

Collaborators

National Institute of Mental Health (NIMH), Columbia University

Enrollment target

~120 participants

Started

February 2026

Primary completion

April 2030

Age range

18 Years – 55 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov